(Q54650659)

2 June 2018

title

CHEK2 mutations in primary glioblastomas. (English)

1 reference

2 June 2018

4

Johanna Schleutker

1 reference

2 June 2018

2

Tarja Ikonen

1 reference

2 June 2018

author name string

Satu-Leena Sallinen

series ordinal

1

1 reference

2 June 2018

Hannu Haapasalo

series ordinal

3

1 reference

2 June 2018

publication date

1 August 2005

1 reference

2 June 2018

Journal of Neuro-Oncology

published in

1 reference

2 June 2018

volume

74

1 reference

2 June 2018

issue

1

1 reference

2 June 2018

page(s)

93-95

1 reference

2 June 2018

https://scigraph.springernature.com/pub.10.1007/s11060-005-5953-7

exact match

0 references

cites work

Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-005-5953-7

Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro

21 January 2018

1 reference

12 December 2020

Characterization of tumor-associated Chk2 mutations

1 reference

12 December 2020

Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation

1 reference

12 December 2020

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

1 reference

12 December 2020

Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors

1 reference

12 December 2020

Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility

1 reference

12 December 2020

The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families

1 reference

12 December 2020

Analysis of theNF2 tumor-suppressor gene and of chromosome 22 deletions in gliomas

1 reference

12 December 2020

CHEK2 variant I157T may be associated with increased breast cancer risk

1 reference

12 December 2020

Analysis of CHK2 in vulval neoplasia

1 reference

12 December 2020

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

1 reference

12 December 2020

Common regions of deletion on chromosome 22q12.3-q13.1 and 22q13.2 in human astrocytomas appear related to malignancy grade.

1 reference

12 December 2020

CHEK2 variants associate with hereditary prostate cancer

1 reference

12 December 2020

Linkage of ATM to cell cycle regulation by the Chk2 protein kinase

1 reference

12 December 2020

The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype

1 reference

12 December 2020

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

1 reference

12 December 2020

Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome

1 reference

12 December 2020

Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis. Comparison of 133 tumours in the context of the WHO 1979 and WHO 1993 grading schemes.

1 reference

12 December 2020

Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2

1 reference

12 December 2020

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

1 reference

12 December 2020

Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53

1 reference

12 December 2020

Histological type-selective, tumor-predominant expression of a novel CHK1 isoform and infrequent in vivo somatic CHK2 mutation in small cell lung cancer

1 reference

12 December 2020

hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response

1 reference

12 December 2020

Mutation analysis of the CHK2 gene in families with hereditary breast cancer

1 reference

12 December 2020

Mutations in CHEK2 associated with prostate cancer risk

1 reference

12 December 2020

Mutation analysis of the hCHK2 gene in primary human malignant gliomas.

1 reference

12 December 2020

CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies

1 reference

12 December 2020

p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition

1 reference

12 December 2020

10.1007/S11060-005-5953-7

Identifiers

DOI

1 reference

2 June 2018

1 reference

2 June 2018